Article
Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jun 2012
Callens Celine, Baleydier Frederic, Lengline Etienne, Ben Abdelali Raouf, Petit Arnaud, Villarese Patrick, Cieslak Agata, Minard-Colin Veronique, Rullier Anne, Moreau Anne, Baruchel André, Schmitt Claudine, Asnafi Vahid, Bertrand Yves, Macintyre Elizabeth
Abstract excerpt
PURPOSE: Pediatric T-cell lymphoblastic lymphomas (T-LBL) are commonly treated on T-cell acute lymphoblastic leukemia (T-ALL) -derived protocols. Therapeutic stratification based on response to the prephase treatment and on minimal residual disease assessment is well established in T-ALL but is not easy to extrapolate to T-LBL. The identification of molecular prognostic markers at diagnosis in T-LBL could provide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
